Official Site of The State of New Jersey
Adults aged 60 and older
- There are three RSV vaccines available: Arexvy (GSK), Abrysvo (Pfizer), and mRESVIA (Moderna).
- The CDC recommends RSV vaccination for:
- Adults aged 60 to 74 who are at increased risk for severe RSV disease.
- Adults aged 75 and older.
More information about RSV vaccines for adults 60 and over .
Infants and young children
To prevent severe RSV disease in infants, the CDC recommends either maternal RSV vaccination or infant immunization with RSV monoclonal antibodies. Most infants will not need both.
Vaccination for pregnant people
- One dose of maternal RSV vaccine during weeks 32 through 36 of pregnancy, administered immediately before or during RSV season (typically fall through spring). Abrysvo is the only RSV vaccine recommended during pregnancy.
Immunization for infants and young children
- One dose of nirsevimab for all infants younger than 8 months born during or entering their first RSV season.
- One dose of nirsevimab for infants and children aged 8–19 months who are at increased risk for severe RSV disease and entering their second RSV season.
Note: A different monoclonal antibody, palivizumab, is limited to children aged 24 months and younger with certain conditions that place them at high risk for severe RSV disease. Talk to your health care provider for more information.
Resources
- RSV FAQ (PDF)
- RSV Vaccination Fact Sheet - English | Spanish
- CDC RSV website
- RSV Vaccination CDC FAQ
- Find your local health department